- Home
- ICG vs XBIT Comparison
ICG vs XBIT Comparison
Compare ICG & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICG
- XBIT
- Stock Information
- Founded
- ICG 2017
- XBIT 2005
- Country
- ICG China
- XBIT United States
- Employees
- ICG N/A
- XBIT N/A
- Industry
- ICG Semiconductors
- XBIT Pharmaceuticals and Biotechnology
- Sector
- ICG Technology
- XBIT Health Care
- Exchange
- ICG Nasdaq
- XBIT Nasdaq
- Market Cap
- ICG 105.7M
- XBIT 93.0M
- IPO Year
- ICG 2023
- XBIT 2015
- Fundamental
- Price
- ICG $2.80
- XBIT $2.83
- Analyst Decision
- ICG Strong Buy
- XBIT
- Analyst Count
- ICG 2
- XBIT 0
- Target Price
- ICG $9.25
- XBIT N/A
- AVG Volume (30 Days)
- ICG 351.4K
- XBIT 185.9K
- Earning Date
- ICG 08-14-2025
- XBIT 08-11-2025
- Dividend Yield
- ICG N/A
- XBIT N/A
- EPS Growth
- ICG N/A
- XBIT N/A
- EPS
- ICG 0.07
- XBIT N/A
- Revenue
- ICG $53,729,346.00
- XBIT N/A
- Revenue This Year
- ICG N/A
- XBIT N/A
- Revenue Next Year
- ICG $141.94
- XBIT N/A
- P/E Ratio
- ICG $38.55
- XBIT N/A
- Revenue Growth
- ICG 384.54
- XBIT N/A
- 52 Week Low
- ICG $1.19
- XBIT $2.50
- 52 Week High
- ICG $12.04
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- ICG 66.82
- XBIT 46.44
- Support Level
- ICG $1.75
- XBIT $2.95
- Resistance Level
- ICG $2.79
- XBIT $3.32
- Average True Range (ATR)
- ICG 0.38
- XBIT 0.17
- MACD
- ICG 0.13
- XBIT 0.01
- Stochastic Oscillator
- ICG 89.18
- XBIT 40.24
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.